Vence L, Schmitt A, Meadows CE, Gress T. Recognizing Guttate Psoriasis and Initiating Appropriate Treatment. W V Med J. 2015 Jul-Aug. 111 (4):26-8. [Medline].
Baker BS, Powles AV, Fry L. A possible role for vaccination in the treatment of psoriasis?. G Ital Dermatol Venereol. 2008. 143(2):105-117.
Nahary L, Tamarkin A, Kayam N, Sela S, Fry L, Baker B, et al. An investigation of antistreptococcal antibody responses in guttate psoriasis. Arch Dermatol Res. 2008 Sep. 300(8):441-9. [Medline].
Ulger Z, Gelenava T, Kosay Y, Darcan S. Acute guttate psoriasis associated with streptococcal perianal dermatitis. Clin Pediatr (Phila). 2007 Jan. 46(1):70-2. [Medline].
Ledoux M, Chazerain V, Saiag P, Mahe E. [Streptococcal perianal dermatitis and guttate psoriasis]. Ann Dermatol Venereol. 2009 Jan. 136(1):37-41. [Medline].
Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol. 2019 Mar - Apr. 37 (2):160-166. [Medline].
Gananandan K, Sacks B, Ewing I. Guttate psoriasis secondary to COVID-19. BMJ Case Rep. 2020 Aug 11. 13 (8):[Medline].
Fang R, Sun Q. Guttate Psoriasis. Indian Pediatr. 2020 Jun 15. 57 (6):596-597. [Medline].
Saleh D, Tanner LS. Guttate Psoriasis. StatPearls [Internet]. 2020 Jan. [Medline]. [Full Text].
Rychik KM, Yousefzadeh N, Glass AT. Guttate psoriasis following presumed coxsackievirus A. Cutis. 2019 Oct. 104 (4):248-249. [Medline].
De Jesús-Gil C, Sans-de San Nicolás L, Ruiz-Romeu E, Ferran M, Soria-Martinez L, Chiriac A, et al. Specific IgA and CLA+ T-Cell IL-17 Response to Streptococcus pyogenes in Psoriasis. J Invest Dermatol. 2020 Jul. 140 (7):1364-1370.e1. [Medline].
Shin MS, Kim SJ, Kim SH, Kwak YG, Park HJ. New Onset Guttate Psoriasis Following Pandemic H1N1 Influenza Vaccination. Ann Dermatol. 2013 Nov. 25(4):489-92. [Medline]. [Full Text].
Vanaki E, Ataei M, Sanati MH, Mansouri P, Mahmoudi M, Zarei F, et al. Expression patterns of Th1/Th2 transcription factors in patients with guttate psoriasis. Acta Microbiol Immunol Hung. 2013 Jun. 60(2):163-74. [Medline].
Hwang YJ, Jung HJ, Kim MJ, Roh NK, Jung JW, Lee YW, et al. Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis. Mediators Inflamm. 2014. 2014:268257. [Medline].
Qian L, Chen W, Sun W, Li M, Zheng R, Qian Q, et al. Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata. Am J Transl Res. 2015. 7 (6):1081-94. [Medline].
Holm SJ, Sakuraba K, Mallbris L, Wolk K, Stahle M, Sanchez FO. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J Invest Dermatol. 2005 Oct. 125(4):721-30. [Medline].
Mallbris L, Wolk K, Sanchez F. HLA-Cw*0602 associates with a twofold higher prevalence of positive strepotococcal throat swab at the onset of psoriasis: a case control study. BMC Dermatol. 2009. 9:5.
Eaton LH, Chularojanamontri L, Ali FR, Theodorakopoulou E, Dearman RJ, Kimber I. Guttate psoriasis is associated with an intermediate phenotype of impaired Langerhans' cell migration. Br J Dermatol. 2014 Mar 13. [Medline].
McFadden JP, Baker BS, Powles AV, Fry L. Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol. 2009 May. 160(5):929-37. [Medline].
Farber EM, Nall L. Epidemiology: Natural history and genetics. In: Roenigk HH, Maibach HI. Psoriasis. 1998. 3rd ed:
Krengel S, Schaumburg-Lever GM, Geilen CC, et al. Krengel S, Schaumburg-Lever GM, Geilen CC, et al. Psoriasis. 1998. 3rd:
Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest. 1995 Nov. 96(5):2106-12. [Medline]. [Full Text].
England RJ, Strachan DR, Knight LC. Streptococcal tonsillitis and its association with psoriasis: a review. Clin Otolaryngol Allied Sci. 1997 Dec. 22(6):532-5. [Medline].
Veraldi S, Lunardon L, Dassoni F. Guttate psoriasis triggered by chickenpox. G Ital Dermatol Venereol. 2009 Aug. 144(4):501-2. [Medline].
Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007 Nov-Dec. 25(6):606-15. [Medline].
Goiriz R, Dauden E, Perez-Gala S, Guhl G, Garcia-Diez A. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol. 2007 Mar. 32(2):176-9. [Medline].
Costa-Romero M, Coto-Segura P, Suarez-Saavedra S, et al. Guttate psoriasis induced by infliximab in a child with Crohn’s disease. Inflamm Bowel Dis. 2008. 14(10):1462-1463.
Cheng H, Geist DE, Piperdi M, Virk R, Piperdi B. Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour. Australas J Dermatol. 2009 Feb. 50(1):41-3. [Medline].
Yamamoto T. Anti-Programmed Cell Death-1-Induced Plaque and Guttate Psoriasis. Indian J Dermatol. 2018 Jan-Feb. 63 (1):88-89. [Medline].
Fan X, Yang S, Sun LD, Liang YH, Gao M, Zhang KY, et al. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population. Acta Derm Venereol. 2007. 87(4):335-40. [Medline].
Pfingstler LF, Maroon M, Mowad C. Guttate psoriasis outcomes. Cutis. 2016 Feb. 97 (2):140-4. [Medline].
Zhang XJ, Zhang AP, Yang S, Gao M, Wei SC, He PP, et al. Association of HLA class I alleles with psoriasis vulgaris in southeastern Chinese Hans. J Dermatol Sci. 2003 Oct. 33(1):1-6. [Medline].
Fry L, Powles AV, Corcoran S, et al. HLA Cw*06 is not essential for streptococcal-induced psoriasis. Br J Dermatol. 2006. 154(5):850-853.
Gudjonsson JE, Karason A, Antonsdottir A, Runarsdottir EH, Hauksson VB, Upmanyu R, et al. Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol. 2003 Feb. 148(2):233-5. [Medline].
Atasoy M, Pirim I, Bayrak OF, Ozdemir S, Ikbal M, Erdem T, et al. Association of HLA class I and class II alleles with psoriasis vulgaris in Turkish population. Influence of type I and II psoriasis. Saudi Med J. 2006 Mar. 27(3):373-6. [Medline].
Carlen LM, Sanchez F, Bergman AC, Becker S, Hirschberg D, Franzen B, et al. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J Invest Dermatol. 2005 Jan. 124(1):63-9. [Medline].
Yazici AC, Karabulut AA, Ozen O, Eksioglu M, Ustun H. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study. J Dermatol. 2007 Jun. 34(6):367-74. [Medline].
Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992 Jan. 128(1):39-42. [Medline].
Wilson AG, Clark I, Heard SR, Munro DD, Kirby JD. Immunoblotting of streptococcal antigens in guttate psoriasis. Br J Dermatol. 1993 Feb. 128(2):151-8. [Medline].
Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol. 2003 Sep. 149(3):530-4. [Medline].
Baker BS, Bokth S, Powles A, et al. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol. 1993. 128(5):493-499.
Villeda-Gabriel G, Santamaria-Cogollos LC, Perez-Lorenzo R, Reyes-Maldonado E, Saul A, Jurado-Santacruz F, et al. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis. Arch Med Res. 1998 Summer. 29(2):143-8. [Medline].
Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med. 1995 Feb 1. 181(2):747-53. [Medline]. [Full Text].
Aydogan K, Tore O, Akcaglar S, Oral B, Ener B, Tunali S, et al. Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis. Int J Dermatol. 2012 Apr 18. [Medline].
Perez-Lorenzo R, Zambrano-Zaragoza JF, Saul A, Jimenez-Zamudio L, Reyes-Maldonado E, Garcia-Latorre E. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol. 1998 Jul. 37(7):524-31. [Medline].
Gunes AT, Fetil E, Akarsu S, Ozbagcivan O, Babayeva L. Possible Triggering Effect of Influenza Vaccination on Psoriasis. J Immunol Res. 2015. 2015:258430. [Medline].
Sbidian E, Eftekahri P, Viguier M, Laroche L, Chosidow O, Gosselin P, et al. National survey of psoriasis flares after 2009 monovalent H1N1/seasonal vaccines. Dermatology. 2014. 229 (2):130-5. [Medline].
Balato A, La Bella S, Gaudiello F, Balato N. Efalizumab-induced guttate psoriasis. Successful management and re-treatment. J Dermatolog Treat. 2008. 19(3):182-4. [Medline].
Kim BY, Choi JW, Kim BR, Youn SW. Histopathological findings are associated with the clinical types of psoriasis but not with the corresponding lesional psoriasis severity index. Ann Dermatol. 2015 Feb. 27 (1):26-31. [Medline].
Krishnamurthy K, Walker A, Gropper CA, Hoffman C. To treat or not to treat? Management of guttate psoriasis and pityriasis rosea in patients with evidence of group A Streptococcal infection. J Drugs Dermatol. 2010 Mar. 9(3):241-50. [Medline].
Mobini N, Toussaint S, Kamino H. Noninfectious erythematous, papular and squamous diseases. 10th ed. Lippincott-Raven Publishers; 2009. In: Lever's Histopathology of the Skin:
Chalmers RJ, O'Sullivan T, Owen CM, Griffiths CE. A systematic review of treatments for guttate psoriasis. Br J Dermatol. 2001 Dec. 145(6):891-4. [Medline].
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May. 58(5):826-50. [Medline].
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009 Apr. 60(4):643-59. [Medline].
Rosenberg EW, Noah PW, Zanolli MD, Skinner RB Jr, Bond MJ, Crutcher N. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J Am Acad Dermatol. 1986 May. 14(5 Pt 1):761-4. [Medline].
Dogan B, Karabudak O, Harmanyeri Y. Antistreptococcal treatment of guttate psoriasis: a controlled study. Int J Dermatol. 2008 Sep. 47(9):950-2. [Medline].
Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol. 2001 Dec. 145(6):886-90. [Medline].
Baughman RD. Search for Streptococcus. Arch Dermatol. 1992 Jan. 128(1):103. [Medline].
Thappa DM, Laxmisha C. Suit PUVA as an effective and safe modality of treatment in guttate psoriasis. J Eur Acad Dermatol Venereol. 2006 Oct. 20(9):1146-7. [Medline].
Borroni G, Vignati G, Zaccone C, Gorani A, Brazzelli V, Rabbiosi G. Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report. Acta Derm Venereol Suppl (Stockh). 1994. 186:159-61. [Medline].
Fernández-Guarino M, Aboín-González S, Velázquez D, Barchino L, Cano N, Lázaro P. Phototherapy with Narrow-Band UVB in Adult Guttate Psoriasis: Results and Patient Assessment. Dermatology. 2016. 232 (5):626-632. [Medline].
Koek MB, Buskens E, van Weelden H, Steegmans PH, Bruijnzeel-Koomen CA, Sigurdsson V. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study). BMJ. 2009 May 7. 338:b1542. [Medline]. [Full Text].
[Guideline] Elmets CA, Lim HW, Stoff B, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019 Sep. 81 (3):775-804. [Medline]. [Full Text].
Wilson JK, Al-Suwaidan SN, Krowchuk D, Feldman SR. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy?. Pediatr Dermatol. 2003 Jan-Feb. 20(1):11-5. [Medline].
Wu W, Debbaneh M, Moslehi H, Koo J, Liao W. Tonsillectomy as a treatment for psoriasis: a review. J Dermatolog Treat. 2014 Dec. 25(6):482-6. [Medline].
Cohn JE, Pfeiffer M, Vernose G. Complete resolution of guttate psoriasis after tonsillectomy. Ear Nose Throat J. 2018 Mar. 97 (3):62-63. [Medline].
Martin BA, Chalmers RJ, Telfer NR. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?. Arch Dermatol. 1996 Jun. 132(6):717-8. [Medline].
Williams RC, McKenzie AW, Roger JH, Joysey VC. HL-A antigens in patients with guttate psoriasis. Br J Dermatol. 1976 Aug. 95(2):163-7. [Medline].